Amino-terminal Enhancer of Split (AES) (N-Term) Peptide
Quick Overview for Amino-terminal Enhancer of Split (AES) (N-Term) Peptide (ABIN1540876)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- QSRHSGSSHL PQQLKFTTSD SCDRIKDEFQ LLQAQYHSLK LECDKLASEK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Aes Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AES (Amino-terminal Enhancer of Split (AES))
-
Background
-
Aes acts as dominant repressor towards other family members. Aes inhibits NF-kappa-B-regulated gene expressionand may be required for the initiation and maintenance of the differentiated state .
Alias Symbols: AL024115, Grg, Grg5
Protein Size: 197 -
Molecular Weight
- 22 kDa
-
Gene ID
- 14797
-
NCBI Accession
- NM_010347, NP_034477
-
UniProt
- P63002
Target
-